Accuracy of magnetic resonance in suspicious breast lesions: A systematic quantitative review and meta-analysis

Breast Cancer Research and Treatment

Volumn 126, Issue 2, 2011, Pages 273-285

  Medeiros, Lidia Rosi ^a   Duarte, Célia Scapin ^b   Rosa, Daniela Dornelles ^a,c   Edelweiss, Maria Isabel ^a,d   Edelweiss, Marcia ^e   Silva, Fábio Rosa ^b   Winnnikow, Erik Paul ^b   Pires, Patrícia Duarte Simões ^b   Rosa, Maria Inês ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c Hospital Femina   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast magnetic resonance; Diagnosis; Magnetic resonance mammography; Meta analysis; MRI; ROC; Sensitivity; Specificity; Systematic review

Indexed keywords

BREAST CANCER; BREAST LESION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; META ANALYSIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ROC CURVE; YOUNG ADULT;

EID: 79958717876     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1326-9     Document Type: Review

References (101)

1. Chatterji M, Mercado CL, Moy L (2010) Optimizing 1.5 Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts. Magn Reson Imaging Clin N Am 18:207-224
2. Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, Helbich T, Heywang-Köbrunner SH, Kaiser WA, Kerin MJ, Mansel RE, Marotti L, Martincich L, Mauriac L, Meijers-Heijboer H, Orecchia R, Panizza P, Ponti A, Purushotham AD, Regitnig P, Del Turco MR, Thibault F, Wilson R (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296-1316
3. Lee CH, Dershaw D, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW (2010) Breast cancer screening with imaging recommendations from the society of breast imaging and the ACR on the use of mam-mography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7:18-27
4. Liberman L, Morris EA, Joo-Young Lee M, Kaplan JB, LaTrenta LR, Menell JH, Abramson AF, Dashnaw SM, Ballon DJ, Dershaw DJ (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR 179:171-178 (Pubitemid 34694831)
5. Linda A, Zuiani C, Bazzochi M, Furlan A, Londero V (2008) Borderline breast lesions diagnose at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results bases on 79 surgically excised lesion. Breast 17:125-131
6. Simmons RM, Osborne MP (2009) The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention. Surg Oncol 8:55-65
7. Houssami N, Ciatto S, Bilous M, Vezzosi V, Bianchi S (2007) Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potencial (B3). Br J Cancer 96:1253-1257 (Pubitemid 46625079)
8. Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES (2001) Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 242(1):58-62
9. Bilous M (2008) Management of lesions of uncertain malignant potential on breast core needle histology: vacuum-assisted excision as an alternative to surgical excision. Breast 17:543-544
10. Whiting P, Weswood ME, Rutjes A, Reittsma JB, Bossuyt P, Kleijnen J (2006) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 6:9-17
11. Reitsma JB, Rujes AW, Whiting P, Vlassov VV, Leeflang MM, Deeks JJ (2009) Assessing methodological quality, chap 9. In: Deek JJ, Bossuyt PM, Gatsonis C (eds) Cochrane handbook for systematic review of diagnostic test accuracy. Version 1.0.0. The Cochrane Collaboration 2009. htpp://srdta.cochrane.org/en/ authors.html. Accessed July 19 2010
12. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 138:40-45
13. Altman DG (1999) Some common problems in medical research. In: Altman DG (ed) Practical statistics for medical research, 9th edn. Chapman, London, pp 396-439
14. Schlesselman JJ, Stolley PD (1982) Csse control studies. Design, conduct, analysis. Oxford University Press, New York, pp 174-177
15. Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC et al (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667-676 (Pubitemid 24106180)
16. Reitsma JB, Glas AS, Rutjes AWS, Scholten R, Bossuy PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produce informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982-990 (Pubitemid 41316441)
17. Littenberg B, Moses LE (1993) Estimating diagnostic accuracy from multiple conflicting reports. Med Decis Making 13:313-321 (Pubitemid 24013154)
18. Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data analytic approaches and some considerations. Stat Med 12:1293-1316 (Pubitemid 23230833)
19. Deeks JJ (2001) Systematic reviews of evaluation of diagnostic and screening tests. In: Egger M, Smith GD, Altman D (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing, London, pp 248-282
20. Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 187:271-281 (Pubitemid 44148267)
21. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM (2008) Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med 149:889-897
22. Jellema P, van der Windt DA, Bruinvels DJ, Kneepkens CM, van der Horst HE (2010) Value of symptoms and additional diagnostic tests for colorectal cancer in primary care. BMJ 340:c1269
23. van der Windt D, Jellema P, Mulder C, Kneepkens F, van der Hors H (2010) Diagnostic testing for celiac disease among patients with abdominal symptoms. JAMA 303:1738-1746
24. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB (2000) Diagnosis and screening. In: Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB (eds) Evidence-base medicine: how to practice and teach EBM, 3rd edn. Churchill Livingstone, London, England, pp 67-93
25. AV Zamora J, Muriel A, Khan KS, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
26. Review Manager (RevMan) [Computer program] (2008) Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration
27. Stata Corporation (2009) Stata Statistical Software version 11. Stata Corporation, College Station, TX
28. Abdolmaleki P, Buadu LD, Naderimansh H (2001) Feature extraction and classification ofbreast cancerondynamic magnetic resonance imaging using artificial network. Cancer Lett 171: 183-191 (Pubitemid 32772805)
29. Alamo L, Fisher U (2001) Contrast-enhanced color Doppler ultrasound characteristics in hypervacular breast tumors: comparison with MRI. Eur Radiol 11:970-977 (Pubitemid 32755560)
30. Bagni B, Francescheto A, Casolo A, De Santis M, Bagni I, Pansini F, Di Leo C (2003) Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 30:1383-1388 (Pubitemid 37247956)
31. Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, Sardanelli F, Giusepptti GM, Simonetu G, Lattazio V, Del Maschio AD (2006) Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of multicenter trial. Am J Roentgenol 186:1723-1732 (Pubitemid 46112539)
32. Berge WA, Gutierrez L, Nessaiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB (2004) Diagnostic accuracy of mam-mography, clinical examination, US, and MR imaging in pre-operative assessment of breast cancer. Radiology 233:830-849
33. Blohmer JU, Oellinger H, Schmidt C, Hufnagl P, Felix R, Lictenegger W (1999) Comparison of various imaging methods with particular evaluation of color Doppler sonography for planning surgery for breast tumors. Arch Gynecol Obstet 262:159-171 (Pubitemid 29197080)
34. Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Lehman C, Pisano ED, Causer P, Schnitt SJ, Smazal SF, Stelling CB, Weatherall PT, Schnall MD (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735-2742 (Pubitemid 39628252)
35. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning L, Hendriks JH, Holland (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique. Radiology 193:777-781
36. Boetes C, Strijk SP, Barentsz JO, van der Sluis RF, Ruijs JH (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231-1234 (Pubitemid 127538350)
37. Boné B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37: 208-213 (Pubitemid 126710106)
38. Boné B, Péntek Z, Perbeck L, Veress B (1997) Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 38: 489-496
39. Buadu LD, Murakami J, Murakami S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S (1996) Breast lesions: correlations of contrast medium enhancement patterns on MR images with histopatologic findings and tumor angio-genesis. Radiology 200:639-649 (Pubitemid 26282258)
40. Cecil KM, Schanall MD, Siegelman ES, Lenkinski RE (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45-54 (Pubitemid 32928270)
41. Choi N, Han B, Choe TH, Kim HS (2005) Three-phase dynamic breast magnetic resonance imaging with two-way subtraction. J Comput Assist Tomogr 29:834-841 (Pubitemid 41689551)
42. Cilotti A, Iacconi C, Marini C, Moreti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilaqua G, Bartolozzi C (2007) Contrast-enhanced MR imaging in patients with BIRADS 3-5 microcalcifications. Radiol Med 112:272-286 (Pubitemid 46474832)
43. Daldrup H, Rydland J, Helbich TH, Bjornerud A, Turetschek K, Kvistad KA, Kaindl E, Link TM, Staudacher K, Shames D, Brasch RC, Haraldseth O, Rummeny EJ (2003) Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial Phase II multicenter trial. Radiology 229:885-892 (Pubitemid 37467597)
44. Daniel BL, Yen YF, Glover HG, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ (1998) Breast disease: dynamic spiral MR imaging. Radiology 209:499-509 (Pubitemid 28503120)
45. Dietzel M, Baltzer PA, Vag T, Herzog A, Gajda M, Camara O, Kaiser WA (2010) The adjacent vessel sign on breast MRI: new data and subgroup analysis for 1084 histologically verified cases. Korean J Radiol 11:178-186
46. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888
47. Fisher DR, Baltzer P, Malich A, Wurdinger S, Freesmeyer MG, Marx C, Kaiser WA (2004) Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography? Eur Radiol 14:394-401 (Pubitemid 38324913)
48. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ (1995) Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 196:143-152
49. Gatzemeier W, Liersch T, Stylianou A, Buttler A, Becker H, Fisher U (1999) Präoperative MR-mammographie beim mam-macarcinom. Sicht Der Chirurg 70:1460-1468
50. Gibbs P, Liney GP, Lowry M, Kneedhaw PJ, Turnbull LW (2004) Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI. Breast 13: 115-121 (Pubitemid 38443607)
51. Gilles R, Meunier M, Lucidarme O, Zafrani B, Guinebretière JM, Tardivon AA, Le Gal M, Vanel D, Neuenschwander S, Cl Arriagada R (1996) Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction. MRI J Comput Assit Tomogr 20:9-14
52. Goto M, Ito H, Akazawa K, Kubota T, Kizu O, Yamada K, Nishimura T (2007) Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features. J Magn Reson Imaging 25:104-112 (Pubitemid 46095205)
53. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV (1993) MR imaging of the breast with rotating delivery of excitation off resonance clinical experience with pathologic correlation. Radiology 187:493-501 (Pubitemid 23127861)
54. Heiberg EV, Perman WH, Herrmann VM, Janney CG (1996) Dyamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magnet Reson Imaging 14:337-348 (Pubitemid 26195067)
55. Heinisch M, Gallowitsch HJ, Mikosch P, Kresnik E, Kumnig G, Gomez I, Lind P, Umschaden HW, Gasser J, Forsthuber EP (2003) Comparison of FDG-PET and dynamic contast-enhanced MRI in the evaluation of suggestive breast lesions. Breast 12: 17-22 (Pubitemid 36395482)
56. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, Gnant M, Staudenhererz A, Rudas M, Wolf G, Mostbeck GH (1997) Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99 m sestamibi scintimammography. Radiology 202:421-429 (Pubitemid 27051737)
57. Hickmann PF, Moore NR, Shepstone BJ (1994) The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging. Br J Radiol 67:14-20 (Pubitemid 24026441)
58. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232(2):585-591 (Pubitemid 38971303)
59. Hulka CA, Edmister WB, Smith BL, Tan L, Sgroi DC, Camphell T, Kopans D (1997) Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205:837-842 (Pubitemid 27516725)
60. Ikeda O, Yamashita Y, Morishita S, Kido T, Kitajima M, Okamura K, Fukuda S, Takahashi (1999) Characterization of breast masses by dynamic enhancer. MR Imaging Acta Radiol 40:585-592
61. Jacobs MA, Barker PB, Bluemke DA, Maranto C, Arnold C, Herskovits EH, Bhujwalla Z (2003) Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 229:225-232 (Pubitemid 37152128)
62. Kelcz F, Furman-Haran E, Grobgeld D, Degani H (2002) Clinical testing of high-spatial resolution parametric contrast-enhanced MR imaging of the breast. Am J Roentgenol 179: 1485-1492 (Pubitemid 35386649)
63. Khouli RE, Macura KJ, Jacobs MA, Khalil TH, Kamel IR, Kamel IR, Dwyer A, Bluemke DA (2009) Dynamic contrast-enhanced MRI oh the breast: quantitative method for kinetic curve type assessment. Am J Roentgenol 193:W295-W300
64. Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM (2000) Dynamic high-apatial-resolution MR imaging of suspicious breast lesion: diagnostic criteria and interobserver variability. Am J Roentgenol 175:35-43 (Pubitemid 30415534)
65. Kuhl CK, Mielcareck P, Klaschik P, Leutner C, Wardelmann E, Gieseke J, Schild HH (1999) Dynamic breast MR imaging are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101-110 (Pubitemid 29161739)
66. Liu PF, Debatin JF, Caduff RF, Kacl G, Garzoli E, Krestin GP (1998) Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 71:501-509 (Pubitemid 28243071)
67. Lucht RE, Knopp MV, Brix G (2001) Classification of signaltime curves from dynamic MR mammography by neural networks. Magn Reson Imaging 19:51-57 (Pubitemid 32274118)
68. Morris EA, Liberman L, Dershaw DD, Kaplan JB, LaTrenta LR, Abramson AF, Ballon DJ (2002) Preoperative MR imaging-guided needle localization of breast lesion. Am J Roentgenol 178:1211-1220 (Pubitemid 34411423)
69. Moy L, Elias K, Patel V, Lee J, Babb JS, Toth HK, Mercado CL (2009) Is breast MRI helpful in the evaluation of inconclusive mammographic findings? Am J Roentgenol 193:986-993
70. Nakahara H, Namba K, Fukami A, Watanabe R, Maeda Y, Furusawa H, Matsu T, Akiyama F, Nakagawa H, Ifuku H, Nakahara M (2001) Three-dimensional MR imaging of mammogaphically detected suspicious microcalcifications. Breast Cancer 8:116-124
71. Nakano S, Yoshida M, Fujii K, Yorozuya K, Mouri Y, Kousaka, Fukutomi T, Kimura J, Ishiguchi T, Ohno K, Mizumoto T, Harao M (2009) Fusion of MRI and sonography image for breast cancer evaluation using real-time virtual sonography with magnetic navigation: first experience. Jpn J Clin Oncol 39: 552-559
72. Newel D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY (2010) Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol 20:771-781
73. Nunes LW, Schnall MD, Orel SG (2001) Update of breast MR imaging architectural interpretation model Radiology 219: 484-494 (Pubitemid 32336366)
74. Obdeijn IM, Kuijpers TA, van Dijk P, Wiggers T, Oudkerk M (1996) MR lesion detection in a breast cancer population. J Magn Reson Imaging 6:849-854 (Pubitemid 126700837)
75. Orel SG, Schnall M, Powell C, Hochman M, Solin LJ, Fowble BL, Torosian Rosato EF (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guide biopsy. Radiology 196:115-122
76. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ (1996) Scintimammography with technetium-99 m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 23:940-946 (Pubitemid 26278794)
77. Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. Am J Roentgenol 194: 1664-1673
78. Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio AM, Kirchin AM (2009) The challenge of imaging dense breast parenchyma. Invest Radiol 44:412-421
79. Reinikainen H, Pääkkö E, Suramo I, Päivänsalo M, Jauhiainen J, Rissanen T (2002) Dynamics of contrast enhancement in MR imaging and Power Doppler ultrasonography of solid breast lesions. Acta Radiol 43:492-500
80. Sardanelli F, Lozzeli A, Fausto A, Carriero A, Kirchin MA (2005) Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsi-lateral increased vascularity. Radiology 235:791-797 (Pubitemid 40695871)
81. Schedel H, Oellinger H, Kohlschein P, Siewert C, Hadjuana J, Blohmer JU, Kissner T, Felix R (2002) Magnetic resonance female breast imaging - evaluation of the changes in signal intensity over time pre- and post-administration of 0, 2 mmol/kg Gd-DTPA. Zentralbi Gynakol 124:104-110 (Pubitemid 34298231)
82. Schmitz AC, Peters NG, Gallardo FAM, van Diest PJ, Stapper G, van Hillegersberg R, Mali WP, van den Bosch MA (2008) Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 18:355-364 (Pubitemid 351234057)
83. Sherif H, Mahfouz AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz, Felix R, Hamm B (1997) Peripheral washout sign on contrast-enhanced MR images of the Breast. Radiology 205: 209-213 (Pubitemid 27415150)
84. Siegmann KC, Xydeas T, Sinkus R, Kraemer B, Vogel U, Claussen CD (2010) Diagnostic value of MR elastography in addition to contrast-enhanced MR imaging of the breast - initial clinical results. Eur Radiol 20:318-325
85. Sinha S, Lucas-Quesada FA, DeBruhi N, Sayre J, Farria D, Gorczyca DP, Bassett LW (1997) Multifeature analysis of Gdenhanced MR images of Breast Lesions. J Magn Reson Imaging 7:1016-1026 (Pubitemid 28372876)
86. Sivarajan U, Jayapragasam KJ, Aziz A, Rahmat K, Bux SI (2009) Dynamic contrast enhancement magnetic resonance imaging evaluation of breast lesions: a morphological and quantitative analysis. J HK Coll Radiol 12:43-52
87. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197:387-395
88. Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch Hahn K (1998) Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detecded by mammography. Nucl Med Commun 19:55-62 (Pubitemid 28085108)
89. Trecate G, Tess JD, Vergnaghi D, Bergonzi S, de Simone T, Mariani G, Musumeci R (2002) Breast microcalcifications studied with 3d contrast-enhanced high field magnectic resonance imaging: more accuracy in the diagnosis of breast cancer. Tumori 88:224-233 (Pubitemid 34875450)
90. Turkat TJ, Klein BD, Polan R, Richman R. Dynamic MR (1994) Mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 4:563-568
91. Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, Fezoulidis IV (2009) Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol 70:69-76
92. Wiberg MK, Aspelin P, Perbeck L, Boné B (2002) Value of MR imaging in clinical evaluation of breast lesion. Acta Radiol 43:275-281
93. Wurdinger S, Kamprath S, Eschrich D, Schneider A, Kaiser WA (2001) False-negative findings of malignant breast lesions on preoperative magnetic resonance mammography. Breast 10: 131-139 (Pubitemid 32390228)
94. Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H (2010) Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Eur J Radiol 75:e126-e132
95. Zhu J, Kurihara Y, Kanemaki Y, Ogata H, Fukuda M, Nakajima Y, Maeda I (2007) Diagnostic accuracy of high-resolution MRI using a microscopy coil for patients with presumed DCIS following mammography screening. J Magn Reson Imaging 25: 96-103 (Pubitemid 46095204)
96. Houssami N, Ciatto S, Macaskill P, Lord S, Warren RM, Dixon JM, Irwig L (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248-3258
97. Hrung JM, Sonnad SS, Schwartz S, Langlotz CP (1999) Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 6:387-397 (Pubitemid 32674945)
98. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671-679 (Pubitemid 351669112)
99. Peters NH, Rinkes IH, Zuithorff N, Mali W, Moons K, Peeters P (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246:116-124 (Pubitemid 350305034)
100. Yeh ED (2010) Breast magnetic resonance imaging: current clinical indications. Magn Reson Imaging Clin N Am 18: 155-169
101. Goscin C, Berman CG, Clark RA (2001). Magnectic resonance imaging of the breast. Cancer Control 8:399-405